Telithromycin

Kathryn Dzintars, Pharm.D., BCPS, Paul A. Pham, Pharm.D.

INDICATIONS

FDA

Mild to moderate severe community-acquired pneumonia due to S. pneumoniae (including multi-drug resistant isolates), H. influenzae, M. catarrhalis, C. pneumoniae, or M. pneumoniae.

NON-FDA APPROVED USES

Sinusitis, acute (FDA indication withdrawn 2007 due to a low benefit vs. risk ratio)
Chronic bronchitis, acute exacerbations (FDA indication withdrawn due to a low benefit vs. risk ratio)
Pharyngitis

There's more to see -- the rest of this topic is available only to subscribers.

© 2000–2025 Unbound Medicine, Inc. All rights reserved

All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.